FDA Says No to OTC Mevacor
The Associated Press/The New York Times
The Food and Drug Administration (FDA) has rejected Merck’s application to take the cholesterol-lowering drug, Mevacor, over-the-counter.
MORE ON THIS STORY...
MORE RETAIL NEWS HEADLINES...
Check out RetailWire's Engaging Online Discussions Featuring Our Exclusive Braintrust!
©2020 RetailWire LLC. All rights reserved.